#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15948	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2287	694.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1501	1501	C	974	C	915	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3504	829.5	0	.	n	.	0	T695C	SNP	695	695	T	1044	1044	C	897	C,T	844,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3504	829.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	1987	1987	G	945	G,A	896,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3504	829.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2320	2320	C	975	C,T,G	905,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3504	829.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2394	2394	A	924	A	880	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3504	829.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2946	2946	C	869	C,T	830,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1956	folP	852	852	99.77	folP.l15.c30.ctg.1	1566	124.1	0	.	p	.	0	S68P	NONSYN	202	204	TCG	545	547	CCG	178;176;174	C;C;G	167;165;163	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1956	folP	852	852	99.77	folP.l15.c30.ctg.1	1566	124.1	0	.	p	.	0	A204V	NONSYN	610	612	GCA	953	955	GTA	204;208;208	G;T,C;A	191;192,1;193	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1956	folP	852	852	99.77	folP.l15.c30.ctg.1	1566	124.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1025	1027	AGC	191;188;187	A;G;C	185;178;179	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4940	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3365	146.3	1	SNP	p	S91F	1	.	.	271	273	TTC	587	589	TTC	178;179;181	T;T;C	166;169;167	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4940	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3365	146.3	1	SNP	p	D95G	1	.	.	283	285	GGC	599	601	GGC	181;179;179	G;G;C	167;165;166	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4940	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3365	146.3	1	SNP	p	G95N	0	.	.	283	285	GGC	599	601	GGC	181;179;179	G;G;C	167;165;166	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1706	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1405	121.0	1	SNP	p	G45D	0	.	.	133	135	GGC	509	511	GGC	197;195;195	G;G;C	186;182;184	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	852	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1127	75.4	0	.	n	.	0	A197.	DEL	197	197	A	692	692	A	210	A	199	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5338	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2832	187.4	1	SNP	p	D86N	0	.	.	256	258	GAC	515	517	GAC	219;217;219	G;A;C	206;201;209	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5338	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2832	187.4	1	SNP	p	S87R	1	.	.	259	261	CGT	518	520	CGT	220;217;218	C,A;G;T	210,1;207;205	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5338	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2832	187.4	1	SNP	p	R87I	0	.	.	259	261	CGT	518	520	CGT	220;217;218	C,A;G;T	210,1;207;205	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5338	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2832	187.4	1	SNP	p	R87W	0	.	.	259	261	CGT	518	520	CGT	220;217;218	C,A;G;T	210,1;207;205	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5338	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2832	187.4	1	SNP	p	S88P	0	.	.	262	264	TCC	521	523	TCC	220;215;218	T;C;C	207;205;204	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4542	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2569	175.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1531	1533	GGC	236;238;234	G;G;C	224;224;219	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1262	1264	GCC	227;229;229	G;C;C	217;220;221	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1265	1267	ATG	232;234;233	A;T;G,C	226;226;226,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1277	1279	ACC	243;243;246	A;C;C	234;234;234	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1277	1279	ACC	243;243;246	A;C;C	234;234;234	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1778	1780	ACC	216;217;217	A;C;C	195;205;207	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1832	1834	GCG	211;211;213	G;C;G	201;203;205	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1832	1834	GCG	211;211;213	G;C;G	201;203;205	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1955	1957	GGT	200;198;197	G,T;G;T	183,1;182;179	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1964	1966	AGC	191;188;185	A;G;C	178;176;174	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4290	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2367	180.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1982	1984	CCG	162;166;164	C,G;C,G;G	120,8;126,3;126	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5990	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3071	194.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1543	1545	CCG	231;228;225	C,T;C;G	211,1;216;208	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2250	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1777	125.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	511	511	C	184	C	171	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3278	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1769	184.4	1	SNP	p	G120K	1	.	.	358	360	AAG	692	694	AAG	281;283;283	A,G;A;G,C	267,1;272;270,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3278	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1769	184.4	1	SNP	p	N121D	0	.	.	361	363	AAC	695	697	AAC	281;282;280	A,G;A;C	270,1;270;272	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3278	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1769	184.4	1	SNP	p	A121N	1	.	.	361	363	AAC	695	697	AAC	281;282;280	A,G;A;C	270,1;270;272	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12362	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4808	256.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1326	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1021	129.1	1	SNP	p	V57M	1	.	.	169	171	ATG	504	506	ATG	264;264;262	A;T;G	252;248;249	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
